Use of Warfarin or Direct Oral Anticoagulants and Risk of Prostate Cancer in PCBaSe: A Nationwide Case-Control Study

Por Jonathan Parker, Danielle Crawley, Hans Garmo, Hans Garmo, Bertil Lindahl, Johan Styrke, Jan Adolfsson, Mats Lambe, Pär Stattin, Mieke Van Hemelrijck, Kerri Beckmann, Kerri Beckmann
Publicado em 2020-10-01

A case-control study of lower urinary-tract infections, associated antibiotics and the risk of developing prostate cancer using PCBaSe 3.0.

Por Beth Russell, Hans Garmo, Kerri Beckmann, Pär Stattin, Jan Adolfsson, Mieke Van Hemelrijck
Publicado em 2018-01-01

Chronic inflammatory diseases, anti-inflammatory medications and risk of prostate cancer: a population-based case-control study

Por Kerri Beckmann, Beth Russell, Debra Josephs, Hans Garmo, Christel Haggstrom, Lars Holmberg, Pär Stattin, Mieke Van Hemelrijck, Jan Adolfsson
Publicado em 2019-06-01

Is there any association between prostate-specific antigen screening frequency and uptake of active surveillance in men with low or very low risk prostate cancer?

Por Kerri Beckmann, Netty Kinsella, Henrik Olsson, Anna Wallerstedt Lantz, Tobias Nordstrom, Markus Aly, Jan Adolfsson, Martin Eklund, Mieke Van Hemelrijck
Publicado em 2019-08-01